Is SESN or RYLD a better dividend investment in 2026?

SESN currently yields 318.07% with a 5% 5-year dividend growth rate. RYLD yields 12.14% with 5% growth. The better choice depends on your goal: SESN offers higher current income.

What is the dividend yield difference between SESN and RYLD?

SESN has a forward dividend yield of 318.07% ($2.00/share annually). RYLD yields 12.14% ($1.81/share annually). The yield gap is 305.93 percentage points.

Home › Compare › SESN vs RYLD

SESN vs RYLD: Dividend Comparison 2026

SESN yields 318.07% · RYLD yields 12.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SESN wins by $2251.78M in total portfolio value

INVESTMENT

TIME HORIZON10 years

SESN

● Live price

318.07%

Share price

$0.63

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$2251.82M

Annual income

$1,391,325,451.55

Full SESN calculator →

RYLD

● Live price

12.14%

Share price

$14.95

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.5K

Annual income

$2,587.35

Full RYLD calculator →

Portfolio growth — SESN vs RYLD

📍 SESN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SESN	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SESN + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SESN pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SESN

Annual income on $10K today (after 15% tax)

$27,035.62/yr

After 10yr DRIP, annual income (after tax)

$1,182,626,633.82/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,031.60/yr

After 10yr DRIP, annual income (after tax)

$2,199.25/yr

At 15% tax rate, SESN beats the other by $1,182,624,434.57/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SESN + RYLD for your $10,000?

SESN: 50%RYLD: 50%

100% RYLD50/50100% SESN

Portfolio after 10yr

$1125.93M

Annual income

$695,664,019.45/yr

Blended yield

61.79%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on SESN right now

SESN

Analyst Ratings

Buy

Hold

Consensus: Buy

Altman Z

-26.2

Piotroski

3/9

RYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SESN buys

RYLD buys

No recent congressional trades found for SESN or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSESNRYLD

Forward yield	318.07% ✓	12.14%
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$2251.82M ✓	$44.5K
Annual income after 10y	$1,391,325,451.55 ✓	$2,587.35
Total dividends collected	$2167.12M ✓	$18.8K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: SESN vs RYLD ($10,000, DRIP)

Year	SESN Portfolio	SESN Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$42,507	$31,806.62	$11,914	$1,213.65	+$30.6K → SESN
2	$171,836	$126,354.35	$14,099	$1,351.30	+$157.7K → SESN
3	$661,246	$477,381.03	$16,580	$1,494.55	+$644.7K → SESN
4	$2,424,371	$1,716,837.53	$19,384	$1,642.61	+$2.40M → SESN
5	$8,476,840	$5,882,763.50	$22,535	$1,794.70	+$8.45M → SESN
6	$28,293,724	$19,223,504.84	$26,063	$1,950.00	+$28.27M → SESN
7	$90,240,261	$59,965,976.10	$29,995	$2,107.69	+$90.21M → SESN
8	$275,301,033	$178,743,953.65	$34,361	$2,266.99	+$275.27M → SESN
9	$804,202,218	$509,630,112.70	$39,194	$2,427.12	+$804.16M → SESN
10	$2,251,821,824	$1,391,325,451.55	$44,525	$2,587.35	+$2251.78M → SESN

SESN vs RYLD: Complete Analysis 2026

SESN — Stock

Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment of bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer; to treat non-muscle invasive carcinoma in situ of the bladder in patients previously treated with BCG; and for the treatment of squamous cell carcinoma of the head and neck, as well as VB6-845d, a product candidate for use in the treatment of various types of an anti-epithelial cell adhesion molecule-positive solid tumors. Sesen Bio, Inc. has an agreement with Leiden University Medical Center to co-develop an imaging agent. The company was formerly known as Eleven Biotherapeutics, Inc. and changed its name to Sesen Bio, Inc. in May 2018. Sesen Bio, Inc. was incorporated in 2008 and is headquartered in Cambridge, Massachusetts.

Full SESN Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this SESN vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SESN vs SCHD SESN vs JEPI SESN vs O SESN vs KO SESN vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.